CELG - Celgene Corp
Earnings Results
Results > 2019 / Q3 > CELG

Celgene Corp ( CELG )

Recent earnings result

  1. Celgene EPS beats by $0.28, beats on revenue

For more information you may also visit their official Investor Relations website.

Events & Annual meetings

Title Date Webcast
Celgene Corporation Q3 2019 Earnings October 31, 2019
Celgene Corporation Q2 2019 Earnings July 30, 2019
s22.q4cdn.com PDF
Celgene Corporation Q1 2019 Earnings Apr 25, 2019
s22.q4cdn.com PDF
Celgene Corporation Q4 2018 Earnings Conference Call January 31, 2019 edge.media-server.com webcast
s22.q4cdn.com PDF
Celgene Corporation Presentation at the 37th Annual J.P. Morgan Healthcare Conference January 7, 2019 jpmorgan.metameetings.net webcast
s22.q4cdn.com PDF
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company January 3, 2019 event.on24.com webcast
s22.q4cdn.com PDF

For more events, you may visit their IR events page below.
https://ir.celgene.com/events-and-presentations/default.aspx


Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.


At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.



Recent results

Books we are reading